BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, Agusti AA, Vogelmeier CF. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2021;203:24-36. [PMID: 33146552 DOI: 10.1164/rccm.202009-3533SO] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Ricard PEH, Mchugh HF, Ramsey S. Cardiovascular and Pulmonary Research: The Year (2020) in Review. Cardiopulm Phys Ther J 2021;32:130-9. [DOI: 10.1097/cpt.0000000000000185] [Reference Citation Analysis]
2 Wang Y, Li Q, Chen W, Jian W, Liang J, Gao Y, Zhong N, Zheng J. Deep Learning-Based Analytic Models Based on Flow-Volume Curves for Identifying Ventilatory Patterns. Front Physiol 2022;13:824000. [DOI: 10.3389/fphys.2022.824000] [Reference Citation Analysis]
3 Shchetinin E, Baturin V, Arushanyan E, Bolatchiev A, Bobryshev D. Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection. Antioxidants 2022;11:140. [DOI: 10.3390/antiox11010140] [Reference Citation Analysis]
4 Miravitlles M, Calle M, Molina J, Almagro P, Gómez J, Trigueros JA, Cosío BG, Casanova C, López-campos JL, Riesco JA, Simonet P, Rigau D, Soriano JB, Ancochea J, Soler-cataluña JJ. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD. Archivos de Bronconeumología 2022;58:T69-81. [DOI: 10.1016/j.arbres.2021.03.026] [Reference Citation Analysis]
5 Lian N, Zhang Q, Chen J, Chen M, Huang J, Lin Q. The Role of Ferroptosis in Bronchoalveolar Epithelial Cell Injury Induced by Cigarette Smoke Extract. Front Physiol 2021;12:751206. [PMID: 34658933 DOI: 10.3389/fphys.2021.751206] [Reference Citation Analysis]
6 Casas-Recasens S, Mendoza N, López-Giraldo A, Garcia T, Cosio BG, Pascual-Guardia S, Acosta-Castro A, Borras-Santos A, Gea J, Garrabou G, Agusti A, Faner R. Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD. Front Med (Lausanne) 2021;8:761767. [PMID: 34901077 DOI: 10.3389/fmed.2021.761767] [Reference Citation Analysis]
7 Han MK, Agusti A, Celli BR, Criner GJ, Halpin DMG, Roche N, Papi A, Stockley RA, Wedzicha J, Vogelmeier CF. From GOLD 0 to Pre-COPD. Am J Respir Crit Care Med 2021;203:414-23. [PMID: 33211970 DOI: 10.1164/rccm.202008-3328PP] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
8 Corwin DS, Ender PT, Sahu N, Durgham RA, McGorry DM Jr, Rahman A, Stoltzfus J, Jahre JA. The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting. Open Forum Infect Dis 2021;8:ofab305. [PMID: 34258324 DOI: 10.1093/ofid/ofab305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Moy ML, Daniel RA, Cruz Rivera PN, Mongiardo MA, Goldstein RL, Higgins DM, Salat DH. Co-occurrence of pain and dyspnea in Veterans with COPD: Relationship to functional status and a pilot study of neural correlates using structural and functional magnetic resonance imaging. PLoS One 2021;16:e0254653. [PMID: 34265003 DOI: 10.1371/journal.pone.0254653] [Reference Citation Analysis]
10 Guo X, Guo D. A Nomogram Based on Comorbidities and Infection Location to Predict 30 Days Mortality of Immunocompromised Patients in ICU: A Retrospective Cohort Study. Int J Gen Med 2021;14:10281-92. [PMID: 34992443 DOI: 10.2147/IJGM.S345632] [Reference Citation Analysis]
11 Calverley PMA. COPD in the time of COVID-19. EClinicalMedicine 2021;34:100832. [PMID: 33880440 DOI: 10.1016/j.eclinm.2021.100832] [Reference Citation Analysis]
12 Zheng W, Wang T, Wu P, Yan Q, Liu C, Wu H, Zhan S, Liu X, Jiang Y, Zhuang H. Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19. Front Pharmacol 2021;12:718874. [PMID: 35002688 DOI: 10.3389/fphar.2021.718874] [Reference Citation Analysis]
13 Wang H, Hou Y, Ma X, Cui L, Bao Y, Xie Y, Li S, Meng X, Li J, Bai G. Multi-omics analysis reveals the mechanisms of action and therapeutic regimens of traditional Chinese medicine, Bufei Jianpi granules: Implication for COPD drug discovery. Phytomedicine 2022;98:153963. [PMID: 35121390 DOI: 10.1016/j.phymed.2022.153963] [Reference Citation Analysis]
14 Liu H, Liang Z, Cao N, Yi X, Tan X, Liu Z, Wang F, Yang Y, Li C, Xiang Z, He Y, Su J, Wang Z, Chen R, Zhou H. Airway bacterial and fungal microbiome in chronic obstructive pulmonary disease. Medicine in Microecology 2021;7:100035. [DOI: 10.1016/j.medmic.2021.100035] [Reference Citation Analysis]
15 Gu J, Yang C, Zhang K, Zhang Q. Mediating role of psychological capital in the relationship between social support and treatment burden among older patients with chronic obstructive pulmonary disease. Geriatr Nurs 2021;42:1172-7. [PMID: 34419869 DOI: 10.1016/j.gerinurse.2021.07.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu X, Du C, Hu F, Zhao Y, Zhou J, Wang Q, Mu Y, Lu J, Gao L, Cui B, Ma Y, Sun T, Qian F, Chen Z. Management of acute exacerbation of chronic obstructive pulmonary disease under a tiered medical system in China. Ther Adv Respir Dis 2022;16:175346662210754. [DOI: 10.1177/17534666221075499] [Reference Citation Analysis]
17 Halpin DMG, Vogelmeier CF, Agusti AA. COPD & COVID-19. Arch Bronconeumol (Engl Ed) 2021;57:162-4. [PMID: 33994646 DOI: 10.1016/j.arbr.2021.01.004] [Reference Citation Analysis]
18 Roh JA, Kim KI, Jung HJ. The efficacy of manual therapy for chronic obstructive pulmonary disease: A systematic review. PLoS One 2021;16:e0251291. [PMID: 34003822 DOI: 10.1371/journal.pone.0251291] [Reference Citation Analysis]
19 Hu X, Xie F, Wang K, Gu H, Mo G, Wen R, Zhao Y, Yang Q, Möller K, Zhao Z, Xie L. Scoring System to Evaluate the Performance of ICU Ventilators in the Pandemic of COVID-19: A Lung Model Study. Front Med (Lausanne) 2021;8:663608. [PMID: 34336879 DOI: 10.3389/fmed.2021.663608] [Reference Citation Analysis]
20 Moreno-martos D, Verhamme K, Ostropolets A, Kostka K, Duarte-sales T, Prieto-alhambra D, Alshammari T, Alghoul H, Ahmed W, Blacketer C, Duvall S, Lai L, Matheny M, Nyberg F, Posada J, Rijnbeek P, Spotnitz M, Sena A, Shah N, Suchard M, Chan You S, Hripcak G, Ryan P, Morales D. Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe. Wellcome Open Res 2022;7:22. [DOI: 10.12688/wellcomeopenres.17403.1] [Reference Citation Analysis]
21 Halpin DMG, Vogelmeier CF, Agusti AA. COPD & COVID-19. Arch Bronconeumol (Engl Ed) 2021;57:162-4. [PMID: 33551276 DOI: 10.1016/j.arbres.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yun J, Cho YH, Lee SM, Hwang J, Lee JS, Oh YM, Lee SD, Loh LC, Ong CK, Seo JB, Kim N. Deep radiomics-based survival prediction in patients with chronic obstructive pulmonary disease. Sci Rep 2021;11:15144. [PMID: 34312450 DOI: 10.1038/s41598-021-94535-4] [Reference Citation Analysis]
23 Li W, Li G, Zhou W, Wang H, Zheng Y, Yang J. Effect of Autoimmune Cell Therapy on Immune Cell Content in Patients with COPD: A Randomized Controlled Trial. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/8361665] [Reference Citation Analysis]
24 Majorski DS, Magnet FS, Thilemann S, Schmoor C, Windisch W, Schwarz SB. Portable NIV for patients with moderate to severe COPD: two randomized crossover trials. Respir Res 2021;22:123. [PMID: 33902562 DOI: 10.1186/s12931-021-01710-2] [Reference Citation Analysis]
25 Naughton PJ, Joyce M, Mac Giolla Eain M, O'Sullivan A, MacLoughlin R. Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era. Pharmaceutics 2021;13:1574. [PMID: 34683867 DOI: 10.3390/pharmaceutics13101574] [Reference Citation Analysis]
26 Liu M, Wu K, Lin J, Xie Q, Liu Y, Huang Y, Zeng J, Yang Z, Wang Y, Dong S, Deng W, Yang M, Wu S, Jiang W, Li X. Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease? Front Pharmacol 2021;12:695957. [PMID: 34305606 DOI: 10.3389/fphar.2021.695957] [Reference Citation Analysis]
27 Deng L, Yan J, Xu H, Huang C, Lv Y, Wu Q, Xu Y, Chen X. Prediction of exacerbation frequency of AECOPD based on next-generation sequencing and its relationship with imbalance of lung and gut microbiota: a protocol of a prospective cohort study. BMJ Open 2021;11:e047202. [PMID: 34475159 DOI: 10.1136/bmjopen-2020-047202] [Reference Citation Analysis]
28 Ribeiro C, Vieira AL, Pamplona P, Drummond M, Seabra B, Ferreira D, Liberato H, Carreiro A, Vicente I, Castro L, Costa P, Carriço F, Martin T, Cravo J, Teixeira N, Grafino M, Conde S, Windisch W, Nunes R. Current Practices in Home Mechanical Ventilation for Chronic Obstructive Pulmonary Disease: A Real-Life Cross-Sectional Multicentric Study. Int J Chron Obstruct Pulmon Dis 2021;16:2217-26. [PMID: 34349507 DOI: 10.2147/COPD.S314826] [Reference Citation Analysis]
29 Yang W, Li F, Li C, Meng J, Wang Y. Focus on Early COPD: Definition and Early Lung Development. Int J Chron Obstruct Pulmon Dis 2021;16:3217-28. [PMID: 34858022 DOI: 10.2147/COPD.S338359] [Reference Citation Analysis]
30 Villar-álvarez F, Martínez-garcía MÁ, Jiménez D, Fariñas-guerrero F, Ortiz de Lejarazu-leonardo R, López-campos JL, Blanco-aparicio M, Royo-crespo Í, García-ortega A, Trilla-garcía A, Trujillo-reyes JC, Fernández-prada M, Díaz-pérez D, Laporta-hernández R, Valenzuela C, Menéndez R, de la Rosa-carrillo D. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias. Open Respiratory Archives 2021;3:100097. [DOI: 10.1016/j.opresp.2021.100097] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Betthauser KD, Eble LN, Juang P, Lizza BD, Micek ST, Kollef MH. Short- Versus Standard-Course Nonmacrolide Antibiotic Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Cohort Study. Clin Ther 2021:S0149-2918(21)00387-8. [PMID: 34736767 DOI: 10.1016/j.clinthera.2021.09.015] [Reference Citation Analysis]
32 El-Saber Batiha G, Al-Gareeb AI, Saad HM, Al-Kuraishy HM. COVID-19 and corticosteroids: a narrative review. Inflammopharmacology 2022. [PMID: 35562628 DOI: 10.1007/s10787-022-00987-z] [Reference Citation Analysis]
33 Brito IL, Schneider L, Hirata RP, Fonseca J, Paes T, Machado FV, Rodrigues A, Hernandes NA, Pitta F. Energy expenditure per minute in different activities and body positions and its association with the classification as physically active or inactive in daily life in individuals with COPD. Chron Respir Dis 2021;18:14799731211053331. [PMID: 34706577 DOI: 10.1177/14799731211053331] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Wang Y, Liao S, Pan Z, Jiang S, Fan J, Yu S, Xue L, Yang J, Ma S, Liu T, Zhang J, Chen Y. Hydrogen sulfide alleviates particulate matter-induced emphysema and airway inflammation by suppressing ferroptosis. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.04.014] [Reference Citation Analysis]
35 Che L, Yu C, Chen G, Lin J, Xie Z, Xia T, Luo W, Cai X, Liu S. The Inflammatory Response Induced by RELMβ Upregulates IL-8 and IL-1β Expression in Bronchial Epithelial Cells in COPD. Int J Chron Obstruct Pulmon Dis 2021;16:2503-13. [PMID: 34511895 DOI: 10.2147/COPD.S321877] [Reference Citation Analysis]
36 Gomes P, Bastos HNE, Carvalho A, Lobo A, Guimarães A, Rodrigues RS, Zin WA, Carvalho ARS. Pulmonary Emphysema Regional Distribution and Extent Assessed by Chest Computed Tomography Is Associated With Pulmonary Function Impairment in Patients With COPD. Front Med (Lausanne) 2021;8:705184. [PMID: 34631729 DOI: 10.3389/fmed.2021.705184] [Reference Citation Analysis]
37 Thu PNT, Huong MNT, Thi NT, Thanh HN, Minh KP. Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial. BMC Infect Dis 2021;21:1019. [PMID: 34587911 DOI: 10.1186/s12879-021-06687-3] [Reference Citation Analysis]
38 Xue M, Zeng Y, Lin R, Qu HQ, Zhang T, Zhang XD, Liang Y, Zhen Y, Chen H, Huang Z, Hu H, Zheng P, Hakonarson H, Zhou L, Sun B. Metabolomic profiling of anaerobic and aerobic energy metabolic pathways in chronic obstructive pulmonary disease. Exp Biol Med (Maywood) 2021;246:1586-96. [PMID: 33957804 DOI: 10.1177/15353702211008808] [Reference Citation Analysis]
39 Liu G, Chen Y, Runa A, Liu J. Diagnostic performance of CO-RADS for COVID-19: a systematic review and meta-analysis. Eur Radiol. [DOI: 10.1007/s00330-022-08576-y] [Reference Citation Analysis]
40 Xiang G, Zhu X, Ma L, Huang H, Wu X, Zhang W, Li S. Clinical guidelines on the application of Internet of Things (IOT) medical technology in the rehabilitation of chronic obstructive pulmonary disease. J Thorac Dis 2021;13:4629-37. [PMID: 34527304 DOI: 10.21037/jtd-21-670] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 López-campos JL, Jiménez-ruiz CA, Meneses Petersen ED, Rabade Castedo C, Asensio Sánchez S, Vaquero Lozano P, Ferrer Espinosa S, Pérez Soriano MDP, de Higes Martínez E, García de Llanos C, Pastor Esplá E, Cabrera César E, Mogrovejo S, Riesco Miranda JA, Barrueco Ferrero M, Callejas González FJ, Sandoval Contreras R, Peña Miguel T, Peris Cardells R, González Dou MV, Guzmán Aguilar JM, Amado CA, Gorordo Unzueta MI, Rois Seijas P, Martínez Muñiz MA, Naval Sendra E, Granda-orive JID, Signes-costa J. [Translated article] Smoking Cessation Units as a Source of COPD Diagnoses: Project 1000-200. Archivos de Bronconeumología 2022. [DOI: 10.1016/j.arbres.2021.05.031] [Reference Citation Analysis]
42 Shyam Prasad Shetty B, Chaya SK, Kumar V S, Mahendra M, Jayaraj BS, Lokesh KS, Ganguly K, Mahesh PA. Inflammatory Biomarkers Interleukin 1 Beta (IL-1β) and Tumour Necrosis Factor Alpha (TNF-α) Are Differentially Elevated in Tobacco Smoke Associated COPD and Biomass Smoke Associated COPD. Toxics 2021;9:72. [PMID: 33915841 DOI: 10.3390/toxics9040072] [Reference Citation Analysis]
43 Wang GD, Li Q, Han YT, Zhang T. A prospective study on clinical effect and immune regulation on cytokines secreted by Th cells of aerosolized Traditional Chinese Medicine on elderly patients with AECOPD. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100282] [Reference Citation Analysis]
44 Huang YC, Lin TY, Wu HT, Chang PJ, Lo CY, Wang TY, Kuo CS, Lin SM, Chung FT, Lin HC, Hsieh MH, Lo YL. Cardiorespiratory coupling is associated with exercise capacity in patients with chronic obstructive pulmonary disease. BMC Pulm Med 2021;21:22. [PMID: 33435937 DOI: 10.1186/s12890-021-01400-1] [Reference Citation Analysis]
45 Al-Moamary MS, Köktūrk N, Idrees MM, Şen E, Juvelekian G, Saleh WA, Zoumot Z, Behbehani N, Hatem A, Masoud HH, Snouber A, van Zyl-Smit RN. Unmet need in the management of chronic obstructive pulmonary disease in the Middle East and Africa region: An expert panel consensus. Respir Med 2021;189:106641. [PMID: 34649155 DOI: 10.1016/j.rmed.2021.106641] [Reference Citation Analysis]
46 Xu Z, Zhu L, Zhan J, Liu L. The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: a meta-analysis and systematic review. Eur J Med Res 2021;26:122. [PMID: 34649617 DOI: 10.1186/s40001-021-00587-7] [Reference Citation Analysis]
47 Meza D, Khuder B, Bailey JI, Rosenberg SR, Kalhan R, Reyfman PA. Mortality from COVID-19 in Patients with COPD: A US Study in the N3C Data Enclave. Int J Chron Obstruct Pulmon Dis 2021;16:2323-6. [PMID: 34413640 DOI: 10.2147/COPD.S318000] [Reference Citation Analysis]
48 Stridsman C, Vanfleteren LEGW, Konradsen JR, Axelsson Fisk S, Pedroletti C, Sjöö Y, Syk J, Sterner T, Lindberg A, Tunsäter A, Nyberg F, Ekberg-Jansson A, Karlsson Sundbaum J. Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD. Eur Respir J 2021;58:2101920. [PMID: 34413151 DOI: 10.1183/13993003.01920-2021] [Reference Citation Analysis]
49 Kahnert K, Lutter JI, Welte T, Alter P, Behr J, Herth F, Kauczor HU, Söhler S, Pfeifer M, Watz H, Vogelmeier CF, Bals R, Jörres RA, Trudzinski FC. Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET. ERJ Open Res 2021;7:00242-2021. [PMID: 34430659 DOI: 10.1183/23120541.00242-2021] [Reference Citation Analysis]
50 Kotlyarov S, Bulgakov A. Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. Cells 2021;10:2978. [PMID: 34831201 DOI: 10.3390/cells10112978] [Reference Citation Analysis]
51 Fernández Fernández E, Joyce M, O'Sullivan A, MacLoughlin R. Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis. Antibiotics (Basel) 2021;10:472. [PMID: 33919035 DOI: 10.3390/antibiotics10050472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Jung T, Vij N. Early Diagnosis and Real-Time Monitoring of Regional Lung Function Changes to Prevent Chronic Obstructive Pulmonary Disease Progression to Severe Emphysema. J Clin Med 2021;10:5811. [PMID: 34945107 DOI: 10.3390/jcm10245811] [Reference Citation Analysis]
53 Li C, Wang D, Yang F, Song Y, Yu X, Liu B, Jia H, Zhou W. The role of clinical characteristics and pulmonary function testing in predicting risk of pneumothorax by CT-guided percutaneous core needle biopsy of the lung. BMC Pulm Med 2021;21:257. [PMID: 34362335 DOI: 10.1186/s12890-021-01625-0] [Reference Citation Analysis]
54 Cohen R, Shteinberg M. Diagnosis and Evaluation of Bronchiectasis. Clinics in Chest Medicine 2022;43:7-22. [DOI: 10.1016/j.ccm.2021.11.001] [Reference Citation Analysis]
55 Smith W, Chinnis S, Durham C, Fowler T. Pulmonary function testing for the primary care nurse practitioner. Nurse Pract 2021;46:14-20. [PMID: 34808641 DOI: 10.1097/01.NPR.0000798216.19617.e4] [Reference Citation Analysis]
56 Flores-Gonzalez J, Cancino-Díaz JC, Chavez-Galan L. Flow Cytometry: From Experimental Design to Its Application in the Diagnosis and Monitoring of Respiratory Diseases. Int J Mol Sci 2020;21:E8830. [PMID: 33266385 DOI: 10.3390/ijms21228830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Chen J, Jiang C, Zheng Y, Zhao D, Wu F, Zhao Z, Zhao J, Li Q, Li B, Peng G, Zhou Y, Ran P. Lung Features in Individuals with Biomass Smoke Exposure Characterized by CT Scan and Changes in Pulmonary Function. Int J Chron Obstruct Pulmon Dis 2021;16:2575-84. [PMID: 34531653 DOI: 10.2147/COPD.S325330] [Reference Citation Analysis]
58 Moreno-martos D, Verhamme K, Ostropolets A, Kostka K, Duarte-sales T, Prieto-alhambra D, Alshammari TM, Alghoul H, Ahmed W, Blacketer C, Duvall S, Lai L, Matheny M, Nyberg F, Posada J, Rijnbeek P, Spotnitz M, Sena A, Shah N, Suchard M, Chan You S, Hripcak G, Ryan P, Morales D. Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe. Wellcome Open Res 2022;7:22. [DOI: 10.12688/wellcomeopenres.17403.2] [Reference Citation Analysis]
59 Firnhaber J. Performance and Interpretation of Office Spirometry. Prim Care 2021;48:645-54. [PMID: 34752275 DOI: 10.1016/j.pop.2021.07.004] [Reference Citation Analysis]
60 Kong Q, Cao Y, Gao Z, Sun J, Zhang H, Du Y, Lv Y, Zhou S, Tang Z, Liu B, Dong J. Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial. Trials 2022;23. [DOI: 10.1186/s13063-022-06057-7] [Reference Citation Analysis]
61 López-Campos JL, Carrasco Hernández L, Ruiz-Duque B, Reinoso-Arija R, Caballero-Eraso C. Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies. Int J Chron Obstruct Pulmon Dis 2021;16:2065-76. [PMID: 34285480 DOI: 10.2147/COPD.S275943] [Reference Citation Analysis]
62 Sun L, Xu A, Li M, Xia X, Li P, Han R, Fei G, Zhou S, Wang R. Effect of Methylation Status of lncRNA-MALAT1 and MicroRNA-146a on Pulmonary Function and Expression Level of COX2 in Patients With Chronic Obstructive Pulmonary Disease. Front Cell Dev Biol 2021;9:667624. [PMID: 34604205 DOI: 10.3389/fcell.2021.667624] [Reference Citation Analysis]
63 Zhou R, Wang P, Li Y, Mou X, Zhao Z, Chen X, Du L, Yang T, Zhan Q, Fang Z. Prediction of Pulmonary Function Parameters Based on a Combination Algorithm. Bioengineering 2022;9:136. [DOI: 10.3390/bioengineering9040136] [Reference Citation Analysis]
64 Cazzola M, Ora J, Calzetta L, Rogliani P, Matera MG. The future of inhalation therapy in chronic obstructive pulmonary disease. Current Research in Pharmacology and Drug Discovery 2022;3:100092. [DOI: 10.1016/j.crphar.2022.100092] [Reference Citation Analysis]
65 Fekete M, Szollosi G, Tarantini S, Lehoczki A, Nemeth AN, Bodola C, Varga L, Varga JT. Metabolic syndrome in patients with COPD: Causes and pathophysiological consequences. Physiol Int 2022. [PMID: 35238797 DOI: 10.1556/2060.2022.00164] [Reference Citation Analysis]
66 Szalontai K, Gémes N, Furák J, Varga T, Neuperger P, Balog JÁ, Puskás LG, Szebeni GJ. Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer. J Clin Med 2021;10:2889. [PMID: 34209651 DOI: 10.3390/jcm10132889] [Reference Citation Analysis]
67 Wu SM, Sun WL, Lee KY, Lin CW, Feng PH, Chuang HC, Ho SC, Chen KY, Chen TT, Liu WT, Tseng CH, Bamodu OA. Determinants of Pulmonary Emphysema Severity in Taiwanese Patients with Chronic Obstructive Pulmonary Disease: An Integrated Epigenomic and Air Pollutant Analysis. Biomedicines 2021;9:1833. [PMID: 34944649 DOI: 10.3390/biomedicines9121833] [Reference Citation Analysis]
68 Rutkowski S. Management Challenges in Chronic Obstructive Pulmonary Disease in the COVID-19 Pandemic: Telehealth and Virtual Reality. J Clin Med 2021;10:1261. [PMID: 33803853 DOI: 10.3390/jcm10061261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
69 Jung Y, Wee JH, Kim JH, Choi HG. The Effects of Previous Asthma and COPD on the Susceptibility to and Severity of COVID-19: A Nationwide Cohort Study in South Korea. J Clin Med 2021;10:4626. [PMID: 34682749 DOI: 10.3390/jcm10204626] [Reference Citation Analysis]
70 Joyce M, McGrath JA, Mac Giolla Eain M, O'Sullivan A, Byrne M, MacLoughlin R. Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation. Pharmaceutics 2021;13:199. [PMID: 33540764 DOI: 10.3390/pharmaceutics13020199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
71 Wang HH, Cheng SL. From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease. Biomedicines 2021;9:1638. [PMID: 34829866 DOI: 10.3390/biomedicines9111638] [Reference Citation Analysis]
72 Cheng Y, Lin S, Hsu C, Fu P. Respiratory Muscle Training Can Improve Cognition, Lung Function, and Diaphragmatic Thickness Fraction in Male and Non-Obese Patients with Chronic Obstructive Pulmonary Disease: A Prospective Study. JPM 2022;12:475. [DOI: 10.3390/jpm12030475] [Reference Citation Analysis]
73 Rodrigues SO, Cunha CMCD, Soares GMV, Silva PL, Silva AR, Gonçalves-de-Albuquerque CF. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease. Pharmaceuticals (Basel) 2021;14:979. [PMID: 34681202 DOI: 10.3390/ph14100979] [Reference Citation Analysis]
74 Sivapalan P, Bikov A, Jensen JU. Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease. Diagnostics (Basel) 2021;11:236. [PMID: 33546498 DOI: 10.3390/diagnostics11020236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]